Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective lifted by stock analysts at Cantor Fitzgerald from $170.00 to $200.00 in a research note issued on Tuesday,Benzinga reports.

Amentum (NYSE:AMTM – Get Free Report) was upgraded by equities researchers at Cantor Fitzgerald to a “hold” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.

Blackwell is still in its early days, but at $11 billion, it made up nearly a third of Nvidia's data-center revenue, Cantor Fitzgerald analyst C.J. Muse noted. (Nvidia's data-center business ...

All Remote - GitLab Inc., (NASDAQ: GTLB), the most comprehensive AI-powered DevSecOps platform, today announced that GitLab ...

Lucid could see continued delivery momentum with the Gravity SUV launch, but analysts see near-term worries with a CEO search ...

Forecast|NASDAQ:ASTS] Shares of satellite-based cellular broadband services firm AST SpaceMobile Inc. (NASDAQ: ASTS) spiked ...

In a report released yesterday, Brett Knoblauch from Cantor Fitzgerald maintained a Buy rating on Sprout Social (SPT – Research Report), with a ...

MannKind (MNKD – Research Report) received a Buy rating and a $9.00 price target from Cantor Fitzgerald analyst Olivia Brayer yesterday. The ...

Abu Dhabi, UAE, February 26th, 2025, ChainwirePhoenix Group PLC (ADX:PHX), a global leader in Bitcoin mining, blockchain, and next-generation digital and AI infrastructure, is excited to announce ...

Applied Materials, Inc. today announced that Brice Hill, Senior Vice President and CFO, will participate in a fireside chat ...